An extensive study of propelling opportunities in, “Neurovascular Devices Market Size, Share & Trends Analysis Report by Product Type (Neurovascular Stents, Embolic Coils, Neurothrombectomy Devices, Access Devices, Embolic Protection Devices, Neurovascular Balloon Catheters, Others), Procedure Type, Technology, Material Type, Indication/Disease Type, Patient Demographics, Deployment Method, Treatment Approach, End-users, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035” A comprehensive report of growing market landscapes in the neurovascular devices sector uncovering key growth drivers including niche market leadership, technology-enabled distribution, and increasing consumer needs supporting neurovascular devices potential to scale globally.
Global Neurovascular Devices Market Forecast 2035:
According to the report, the neurovascular devices market is anticipated to grow from USD 5.6 Billion in 2025 to USD 12.2 Billion in 2035 at a CAGR of 8.1% during the forecast. The neurovascular devices market is experiencing strong growth as a result of an aging population in North American and European countries and increased investments in outpatient and virtual care models. Technologies developed by private companies and vendors are fostering advancements in telehealth and remote patient monitoring in North America and Europe. In addition, VR-based training programs help build the clinical workforce while strengthening clinical care techniques.
Increasingly, AI-based solution services are being implemented to enable personalized treatment and scalable care services, in anticipation of increasing demand in both developed and developing countries. Additionally, the increased focus toward home care and remote monitoring behavior change, spurred by the Covid-19 pandemic and healthcare system changes, further influences market growth. Investment in cyber security is also climbing to protect against the growing amount of patient data from connected neurovascular devices.
“Key Driver, Restraint, and Growth Opportunity Defining the Global Neurovascular Devices Market”
The global neurovascular devices market is growing, propelled by the rising prevalence of autoimmune and chronic disease and escalating patient demand for convenient, patient-centered home care. Advances in telehealth, AI-enabled monitoring, and digital health technology are ushering in the development of personalized treatment solutions and ongoing remote care offering additional market momentum.
However, growth is restricted by challenges of limited reimbursement by insurance, a current gap in the home health workforce, and the burden of monitoring for safety and quality. There are also issues around continuity of care.
Despite these challenges and the potential defect in continuity of care, opportunities exist at the nexus of developing digital health solutions and patient demand or in home-based therapies growing. Ongoing investment in healthcare systems and technology-enabled models of care will allow for market growth.
"Impact of Global Tariff Policies on the Global Neurovascular Devices Market Growth and Strategy"
International tariffs negatively impact the neurovascular devices market by increasing the pricing of important medical devices and therapies. Tariffs on biologics, diagnostic equipment or infusion equipment from China or Mexico, for instance, might dramatically increase their prices. If manufacturers implement tariffs into their cost increase, patients might have difficulty accessing significant neurovascular therapies.
In order to mitigate supply chain challenges, manufacturers are diversifying sourcing practices to build domestic production to be less reliant upon suppliers overseas. Additionally, many companies are also investing in technology and systems to improve efficiency and reduce prices. Policymakers should thoughtfully consider the impact of tariffs on price and access to health care when developing and implementing tariff policies relevant to the neurovascular devices market.
Expansion of Global Neurovascular Devices Market
“Aging Demographics, Tech-Enabled Home Care, and Shift to Value-Based Models Accelerate Neurovascular Devices Market Growth”
- The neurovascular devices market is undergoing considerable growth due to various factors. One significant contributor to this growth is the aging global population. The World Health Organization anticipates that one in every six people will be aged 60 or more by 2030. With the increased aging population, the prevalence of neurovascular conditions, including strokes and aneurysms, also increases, thereby creating demand for modern neurovascular devices.
- Additionally, to the growing aging population, value-based care models have been expanding, focusing on quality outcomes and driving down costs in healthcare. Value-based care models reward providers for having efficient and effective treatment, which is likely increasing demand in this category of the health care market.
- With respect to demographics, advancements in technologies is positioning itself to be a driver in growth. Technology has advanced minimally invasive procedures, including specialized procedures featuring complex neurointerventional devices, have emerged and represent an impressive biological/technological progression in treating complex neurovascular conditions. Technology and devices improve the quality of care provided to patients and align with the transference of care models going to-home based and remote care models.
Regional Analysis of Global Neurovascular Devices Market
- North America is at the forefront of the neurovascular devices market, with high quality healthcare infrastructure, strict FDA guidelines, and early adoption of AI-integrated diagnostic technologies and treatments. In March 2025, Medtronic entered a partnership with Google Health, to help deploy AI-integrated stroke detection tools to a selection of major hospitals in the United States. These technologies improved early intervention and patient outcomes.
- Asia Pacific is growing rapidly due to increased prevalence of neurovascular diseases, as well as increased access to healthcare. In 2025, Siemens Healthineers, partnered with several of China’s top neurological centers, to bring stroke patients remote monitoring systems to help facilitate their care in areas of the country that are traditionally underserved. The increasing health care spending, as well as technology adoption in this region is expected to bolster the growth of the marketplace.
- Europe is experiencing growth through strict regulatory structures and public health funding initiatives aimed at reducing strokes. Towards the end of 2024, Roche launched an AI neurovascular imaging platform in several hospitals within Germany, helping to improve treatment personalization and diagnostic accuracy. Initiatives focusing on sustainability and innovation in research and development, will help ensure steady growth throughout the Europe in regards to neurovascular devices.
Key players in the global neurovascular devices market include prominent companies such as Abbott Laboratories (Abbott Vascular), Acandis GmbH, Asahi Intecc Co., Ltd., Balt Extrusion (Balt Group), Boston Scientific Corporation, Cerus Endovascular, Imperative Care, Inc., InNeuroCo, Inc., Integer Holdings Corporation, Johnson & Johnson (Cerenovus), Medtronic plc, Merit Medical Systems, Inc., MicroPort Scientific Corporation, MicroVention, Inc. (Terumo Corporation), Penumbra, Inc., Perflow Medical Ltd., Phenox GmbH, Rapid Medical Ltd., Stryker Corporation, Zylox-Tonbridge Medical Technology Co., Ltd., along with several other key players contributing to market growth through innovation, strategic partnerships, and global expansion.
The global neurovascular devices market has been segmented as follows:
Global Neurovascular Devices Market Analysis, by Product Type
- Neurovascular Stents
- Flow Diverters
- Self-Expanding Stents
- Balloon-Expandable Stents
- Others
- Embolic Coils
- Detachable Coils
- Pushable Coils
- Bare Platinum Coils
- Others
- Neurothrombectomy Devices
- Stent Retrievers
- Aspiration Devices
- Others
- Access Devices
- Embolic Protection Devices
- Neurovascular Balloon Catheters
- Others
Global Neurovascular Devices Market Analysis, by Procedure Type
- Cerebral Aneurysm Treatment
- Ischemic Stroke Intervention
- Arteriovenous Malformation (AVM) Treatment
- Carotid Artery Stenosis Treatment
- Intracranial Atherosclerotic Disease Treatment
- Hemorrhagic Stroke Management
- Venous Sinus Thrombosis Treatment
- Others
Global Neurovascular Devices Market Analysis, by Technology
- Mechanical Thrombectomy
- Endovascular Coiling
- Flow Diversion Technology
- Liquid Embolization
- Angioplasty and Stenting
- Balloon-Assisted Coiling
- Others
Global Neurovascular Devices Market Analysis, by Material Type
- Nitinol-Based Devices
- Platinum-Based Devices
- Stainless Steel Devices
- Polymer-Based Devices
- Cobalt Chromium Devices
- Hybrid Material Devices
Global Neurovascular Devices Market Analysis, by Indication/Disease Type
- Cerebral Aneurysms
- Acute Ischemic Stroke
- Carotid Stenosis
- Intracranial Stenosis
- Arteriovenous Malformations
- Dural Arteriovenous Fistulas
- Vasospasm
- Brain Tumors
- Others
Global Neurovascular Devices Market Analysis, by Patient Demographics
- Pediatric (<18 years)
- Adults (18-64 years)
- Geriatric (65+ years)
Global Neurovascular Devices Market Analysis, by Deployment Method
- Catheter-Based Delivery
- Microcatheter Delivery
- Guide Catheter Systems
- Direct Puncture Systems
Global Neurovascular Devices Market Analysis, by Treatment Approach
- Minimally Invasive Procedures
- Hybrid Procedures
- Emergency/Acute Treatment
- Elective/Planned Procedures
Global Neurovascular Devices Market Analysis, by End-users
- Hospitals
- Emergency Stroke Treatment
- Aneurysm Repair Surgery
- Elective Neurovascular Procedures
- Intensive Care Management
- Inpatient Rehabilitation
- Others
- Ambulatory Surgical Centers (ASCs)
- Day-Case Neurovascular Procedures
- Diagnostic Angiography
- Minor Embolization Procedures
- Follow-up Interventions
- Others
- Specialized Neurovascular Centers
- Complex Aneurysm Treatment
- Advanced Stroke Intervention
- AVM Treatment
- Clinical Trials & Research
- High-Risk Patient Management
- Others
- Catheterization Laboratories
- Research & Academic Institutions
- Rehabilitation Centers
- Others
Global Neurovascular Devices Market Analysis, by Region
- North America
- Europe
- Asia Pacific
- Middle East
- Africa
- South America
About Us
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
Contact US
USA Address:
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
India Address:
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Sources
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Sources
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Global Neurovascular Devices Market Outlook
- 2.1.1. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End-use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2025-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. Global Neurovascular Devices Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Global Neurovascular Devices Industry Overview, 2025
- 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Source Roadmap and Developments
- 3.4. Trade Analysis
- 3.4.1. Import & Export Analysis, 2025
- 3.4.2. Top Importing Countries
- 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
- 3.5.1. Manufacturer
- 3.5.2. Supply Chain
- 3.5.3. End Consumer
- 3.6. Raw Material Analysis
- 3.1. Global Neurovascular Devices Industry Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Increasing Safety Regulations Mandating Advanced Neurovascular Devices Globally
- 4.1.2. Restraints
- 4.1.2.1. High Manufacturing and Procedure Costs Limiting Widespread Adoption of Advanced Neurovascular Devices
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
- 4.4.1. Component Suppliers
- 4.4.2. Manufacturing and Processing
- 4.4.3. Wholesalers/ E-commerce Platform
- 4.4.4. End-use/ Customers
- 4.5. Cost Structure Analysis
- 4.5.1. Parameter’s Share for Cost Associated
- 4.5.2. COGP vs COGS
- 4.5.3. Profit Margin Analysis
- 4.6. Pricing Analysis
- 4.6.1. Regional Pricing Analysis
- 4.6.2. Segmental Pricing Trends
- 4.6.3. Factors Influencing Pricing
- 4.7. Porter’s Five Forces Analysis
- 4.8. PESTEL Analysis
- 4.9. Global Neurovascular Devices Market Demand
- 4.9.1. Historical Market Size – (Value - USD Bn and Volume - Million Units), 2021-2024
- 4.9.2. Current and Future Market Size – (Value - USD Bn and Volume - Million Units), 2025–2035
- 4.9.2.1. Y-o-Y Growth Trends
- 4.9.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. Global Neurovascular Devices Market Analysis, by Product Type
- 6.1. Key Segment Analysis
- 6.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Product Type, 2021-2035
- 6.2.1. Neurovascular Stents
- 6.2.1.1. Flow Diverters
- 6.2.1.2. Self-Expanding Stents
- 6.2.1.3. Balloon-Expandable Stents
- 6.2.1.4. Others
- 6.2.2. Embolic Coils
- 6.2.2.1. Detachable Coils
- 6.2.2.2. Pushable Coils
- 6.2.2.3. Bare Platinum Coils
- 6.2.2.4. Others
- 6.2.3. Neurothrombectomy Devices
- 6.2.3.1. Stent Retrievers
- 6.2.3.2. Aspiration Devices
- 6.2.3.3. Others
- 6.2.4. Access Devices
- 6.2.5. Embolic Protection Devices
- 6.2.6. Neurovascular Balloon Catheters
- 6.2.7. Others
- 6.2.1. Neurovascular Stents
- 7. Global Neurovascular Devices Market Analysis, by Procedure Type
- 7.1. Key Segment Analysis
- 7.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Procedure Type, 2021-2035
- 7.2.1. Cerebral Aneurysm Treatment
- 7.2.2. Ischemic Stroke Intervention
- 7.2.3. Arteriovenous Malformation (AVM) Treatment
- 7.2.4. Carotid Artery Stenosis Treatment
- 7.2.5. Intracranial Atherosclerotic Disease Treatment
- 7.2.6. Hemorrhagic Stroke Management
- 7.2.7. Venous Sinus Thrombosis Treatment
- 7.2.8. Others
- 8. Global Neurovascular Devices Market Analysis, by Technology
- 8.1. Key Segment Analysis
- 8.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Technology, 2021-2035
- 8.2.1. Mechanical Thrombectomy
- 8.2.2. Endovascular Coiling
- 8.2.3. Flow Diversion Technology
- 8.2.4. Liquid Embolization
- 8.2.5. Angioplasty and Stenting
- 8.2.6. Balloon-Assisted Coiling
- 8.2.7. Others
- 9. Global Neurovascular Devices Market Analysis, by Material Type
- 9.1. Key Segment Analysis
- 9.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Material Type, 2021-2035
- 9.2.1. Nitinol-Based Devices
- 9.2.2. Platinum-Based Devices
- 9.2.3. Stainless Steel Devices
- 9.2.4. Polymer-Based Devices
- 9.2.5. Cobalt Chromium Devices
- 9.2.6. Hybrid Material Devices
- 10. Global Neurovascular Devices Market Analysis, by Indication/Disease Type
- 10.1. Key Segment Analysis
- 10.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Indication/Disease Type, 2021-2035
- 10.2.1. Cerebral Aneurysms
- 10.2.2. Acute Ischemic Stroke
- 10.2.3. Carotid Stenosis
- 10.2.4. Intracranial Stenosis
- 10.2.5. Arteriovenous Malformations
- 10.2.6. Dural Arteriovenous Fistulas
- 10.2.7. Vasospasm
- 10.2.8. Brain Tumors
- 10.2.9. Others
- 11. Global Neurovascular Devices Market Analysis, by Patient Demographics
- 11.1. Key Segment Analysis
- 11.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Patient Demographics, 2021-2035
- 11.2.1. Pediatric (<18 years)
- 11.2.2. Adults (18-64 years)
- 11.2.3. Geriatric (65+ years)
- 12. Global Neurovascular Devices Market Analysis, by Deployment Method
- 12.1. Key Segment Analysis
- 12.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Deployment Method, 2021-2035
- 12.2.1. Catheter-Based Delivery
- 12.2.2. Microcatheter Delivery
- 12.2.3. Guide Catheter Systems
- 12.2.4. Direct Puncture Systems
- 13. Global Neurovascular Devices Market Analysis, by Treatment Approach
- 13.1. Key Segment Analysis
- 13.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Treatment Approach, 2021-2035
- 13.2.1. Minimally Invasive Procedures
- 13.2.2. Hybrid Procedures
- 13.2.3. Emergency/Acute Treatment
- 13.2.4. Elective/Planned Procedures
- 14. Global Neurovascular Devices Market Analysis, by End-users
- 14.1. Key Segment Analysis
- 14.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by End-users, 2021-2035
- 14.2.1. Hospitals
- 14.2.1.1. Emergency Stroke Treatment
- 14.2.1.2. Aneurysm Repair Surgery
- 14.2.1.3. Elective Neurovascular Procedures
- 14.2.1.4. Intensive Care Management
- 14.2.1.5. Inpatient Rehabilitation
- 14.2.1.6. Others
- 14.2.2. Ambulatory Surgical Centers (ASCs)
- 14.2.2.1. Day-Case Neurovascular Procedures
- 14.2.2.2. Diagnostic Angiography
- 14.2.2.3. Minor Embolization Procedures
- 14.2.2.4. Follow-up Interventions
- 14.2.2.5. Others
- 14.2.3. Specialized Neurovascular Centers
- 14.2.3.1. Complex Aneurysm Treatment
- 14.2.3.2. Advanced Stroke Intervention
- 14.2.3.3. AVM Treatment
- 14.2.3.4. Clinical Trials & Research
- 14.2.3.5. High-Risk Patient Management
- 14.2.3.6. Others
- 14.2.4. Catheterization Laboratories
- 14.2.5. Research & Academic Institutions
- 14.2.6. Rehabilitation Centers
- 14.2.7. Others
- 14.2.1. Hospitals
- 15. Global Neurovascular Devices Market Analysis and Forecasts, by Region
- 15.1. Key Findings
- 15.2. Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, by Region, 2021-2035
- 15.2.1. North America
- 15.2.2. Europe
- 15.2.3. Asia Pacific
- 15.2.4. Middle East
- 15.2.5. Africa
- 15.2.6. South America
- 16. North America Global Neurovascular Devices Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. North America Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, 2021-2035
- 16.3.1. Product Type
- 16.3.2. Procedure Type
- 16.3.3. Technology
- 16.3.4. Material Type
- 16.3.5. Indication/Disease Type
- 16.3.6. Patient Demographics
- 16.3.7. Deployment Method
- 16.3.8. Treatment Approach
- 16.3.9. End-users
- 16.3.10. Country
- 16.3.10.1. USA
- 16.3.10.2. Canada
- 16.3.10.3. Mexico
- 16.4. USA Global Neurovascular Devices Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Product Type
- 16.4.3. Procedure Type
- 16.4.4. Technology
- 16.4.5. Material Type
- 16.4.6. Indication/Disease Type
- 16.4.7. Patient Demographics
- 16.4.8. Deployment Method
- 16.4.9. Treatment Approach
- 16.4.10. End-users
- 16.5. Canada Global Neurovascular Devices Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Product Type
- 16.5.3. Procedure Type
- 16.5.4. Technology
- 16.5.5. Material Type
- 16.5.6. Indication/Disease Type
- 16.5.7. Patient Demographics
- 16.5.8. Deployment Method
- 16.5.9. Treatment Approach
- 16.5.10. End-users
- 16.6. Mexico Global Neurovascular Devices Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Product Type
- 16.6.3. Procedure Type
- 16.6.4. Technology
- 16.6.5. Material Type
- 16.6.6. Indication/Disease Type
- 16.6.7. Patient Demographics
- 16.6.8. Deployment Method
- 16.6.9. Treatment Approach
- 16.6.10. End-users
- 17. Europe Global Neurovascular Devices Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Europe Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, 2021-2035
- 17.3.1. Product Type
- 17.3.2. Procedure Type
- 17.3.3. Technology
- 17.3.4. Material Type
- 17.3.5. Indication/Disease Type
- 17.3.6. Patient Demographics
- 17.3.7. Deployment Method
- 17.3.8. Treatment Approach
- 17.3.9. End-users
- 17.3.10. Country
- 17.3.10.1. Germany
- 17.3.10.2. United Kingdom
- 17.3.10.3. France
- 17.3.10.4. Italy
- 17.3.10.5. Spain
- 17.3.10.6. Netherlands
- 17.3.10.7. Nordic Countries
- 17.3.10.8. Poland
- 17.3.10.9. Russia & CIS
- 17.3.10.10. Rest of Europe
- 17.4. Germany Global Neurovascular Devices Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Product Type
- 17.4.3. Technology
- 17.4.4. Disease Indication/Therapeutic Area
- 17.4.5. Test Type
- 17.4.6. Sample Type
- 17.4.7. Mode of Purchase
- 17.4.8. Setting/Point of Care
- 17.4.9. Modality/Treatment Approach
- 17.4.10. End-users
- 17.5. United Kingdom Global Neurovascular Devices Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Product Type
- 17.5.3. Procedure Type
- 17.5.4. Technology
- 17.5.5. Material Type
- 17.5.6. Indication/Disease Type
- 17.5.7. Patient Demographics
- 17.5.8. Deployment Method
- 17.5.9. Treatment Approach
- 17.5.10. End-users
- 17.6. France Global Neurovascular Devices Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Product Type
- 17.6.3. Procedure Type
- 17.6.4. Technology
- 17.6.5. Material Type
- 17.6.6. Indication/Disease Type
- 17.6.7. Patient Demographics
- 17.6.8. Deployment Method
- 17.6.9. Treatment Approach
- 17.6.10. End-users
- 17.7. Italy Global Neurovascular Devices Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Product Type
- 17.7.3. Procedure Type
- 17.7.4. Technology
- 17.7.5. Material Type
- 17.7.6. Indication/Disease Type
- 17.7.7. Patient Demographics
- 17.7.8. Deployment Method
- 17.7.9. Treatment Approach
- 17.7.10. End-users
- 17.8. Spain Global Neurovascular Devices Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Product Type
- 17.8.3. Procedure Type
- 17.8.4. Technology
- 17.8.5. Material Type
- 17.8.6. Indication/Disease Type
- 17.8.7. Patient Demographics
- 17.8.8. Deployment Method
- 17.8.9. Treatment Approach
- 17.8.10. End-users
- 17.9. Netherlands Global Neurovascular Devices Market
- 17.9.1. Country Segmental Analysis
- 17.9.2. Product Type
- 17.9.3. Procedure Type
- 17.9.4. Technology
- 17.9.5. Material Type
- 17.9.6. Indication/Disease Type
- 17.9.7. Patient Demographics
- 17.9.8. Deployment Method
- 17.9.9. Treatment Approach
- 17.9.10. End-users
- 17.10. Nordic Countries Global Neurovascular Devices Market
- 17.10.1. Country Segmental Analysis
- 17.10.2. Product Type
- 17.10.3. Procedure Type
- 17.10.4. Technology
- 17.10.5. Material Type
- 17.10.6. Indication/Disease Type
- 17.10.7. Patient Demographics
- 17.10.8. Deployment Method
- 17.10.9. Treatment Approach
- 17.10.10. End-users
- 17.11. Poland Global Neurovascular Devices Market
- 17.11.1. Country Segmental Analysis
- 17.11.2. Product Type
- 17.11.3. Procedure Type
- 17.11.4. Technology
- 17.11.5. Material Type
- 17.11.6. Indication/Disease Type
- 17.11.7. Patient Demographics
- 17.11.8. Deployment Method
- 17.11.9. Treatment Approach
- 17.11.10. End-users
- 17.12. Russia & CIS Global Neurovascular Devices Market
- 17.12.1. Country Segmental Analysis
- 17.12.2. Product Type
- 17.12.3. Procedure Type
- 17.12.4. Technology
- 17.12.5. Material Type
- 17.12.6. Indication/Disease Type
- 17.12.7. Patient Demographics
- 17.12.8. Deployment Method
- 17.12.9. Treatment Approach
- 17.12.10. End-users
- 17.13. Rest of Europe Global Neurovascular Devices Market
- 17.13.1. Country Segmental Analysis
- 17.13.2. Product Type
- 17.13.3. Procedure Type
- 17.13.4. Technology
- 17.13.5. Material Type
- 17.13.6. Indication/Disease Type
- 17.13.7. Patient Demographics
- 17.13.8. Deployment Method
- 17.13.9. Treatment Approach
- 17.13.10. End-users
- 18. Asia Pacific Global Neurovascular Devices Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. East Asia Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, 2021-2035
- 18.3.1. Product Type
- 18.3.2. Procedure Type
- 18.3.3. Technology
- 18.3.4. Material Type
- 18.3.5. Indication/Disease Type
- 18.3.6. Patient Demographics
- 18.3.7. Deployment Method
- 18.3.8. Treatment Approach
- 18.3.9. End-users
- 18.3.10. Country
- 18.3.10.1. China
- 18.3.10.2. India
- 18.3.10.3. Japan
- 18.3.10.4. South Korea
- 18.3.10.5. Australia and New Zealand
- 18.3.10.6. Indonesia
- 18.3.10.7. Malaysia
- 18.3.10.8. Thailand
- 18.3.10.9. Vietnam
- 18.3.10.10. Rest of Asia-Pacific
- 18.4. China Global Neurovascular Devices Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Product Type
- 18.4.3. Procedure Type
- 18.4.4. Technology
- 18.4.5. Material Type
- 18.4.6. Indication/Disease Type
- 18.4.7. Patient Demographics
- 18.4.8. Deployment Method
- 18.4.9. Treatment Approach
- 18.4.10. End-users
- 18.5. India Global Neurovascular Devices Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Product Type
- 18.5.3. Procedure Type
- 18.5.4. Technology
- 18.5.5. Material Type
- 18.5.6. Indication/Disease Type
- 18.5.7. Patient Demographics
- 18.5.8. Deployment Method
- 18.5.9. Treatment Approach
- 18.5.10. End-users
- 18.6. Japan Global Neurovascular Devices Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Product Type
- 18.6.3. Procedure Type
- 18.6.4. Technology
- 18.6.5. Material Type
- 18.6.6. Indication/Disease Type
- 18.6.7. Patient Demographics
- 18.6.8. Deployment Method
- 18.6.9. Treatment Approach
- 18.6.10. End-users
- 18.7. South Korea Global Neurovascular Devices Market
- 18.7.1. Country Segmental Analysis
- 18.7.2. Product Type
- 18.7.3. Procedure Type
- 18.7.4. Technology
- 18.7.5. Material Type
- 18.7.6. Indication/Disease Type
- 18.7.7. Patient Demographics
- 18.7.8. Deployment Method
- 18.7.9. Treatment Approach
- 18.7.10. End-users
- 18.8. Australia and New Zealand Global Neurovascular Devices Market
- 18.8.1. Country Segmental Analysis
- 18.8.2. Product Type
- 18.8.3. Procedure Type
- 18.8.4. Technology
- 18.8.5. Material Type
- 18.8.6. Indication/Disease Type
- 18.8.7. Patient Demographics
- 18.8.8. Deployment Method
- 18.8.9. Treatment Approach
- 18.8.10. End-users
- 18.9. Indonesia Global Neurovascular Devices Market
- 18.9.1. Country Segmental Analysis
- 18.9.2. Product Type
- 18.9.3. Procedure Type
- 18.9.4. Technology
- 18.9.5. Material Type
- 18.9.6. Indication/Disease Type
- 18.9.7. Patient Demographics
- 18.9.8. Deployment Method
- 18.9.9. Treatment Approach
- 18.9.10. End-users
- 18.10. Malaysia Global Neurovascular Devices Market
- 18.10.1. Country Segmental Analysis
- 18.10.2. Product Type
- 18.10.3. Procedure Type
- 18.10.4. Technology
- 18.10.5. Material Type
- 18.10.6. Indication/Disease Type
- 18.10.7. Patient Demographics
- 18.10.8. Deployment Method
- 18.10.9. Treatment Approach
- 18.10.10. End-users
- 18.11. Thailand Global Neurovascular Devices Market
- 18.11.1. Country Segmental Analysis
- 18.11.2. Product Type
- 18.11.3. Procedure Type
- 18.11.4. Technology
- 18.11.5. Material Type
- 18.11.6. Indication/Disease Type
- 18.11.7. Patient Demographics
- 18.11.8. Deployment Method
- 18.11.9. Treatment Approach
- 18.11.10. End-users
- 18.12. Vietnam Global Neurovascular Devices Market
- 18.12.1. Country Segmental Analysis
- 18.12.2. Product Type
- 18.12.3. Procedure Type
- 18.12.4. Technology
- 18.12.5. Material Type
- 18.12.6. Indication/Disease Type
- 18.12.7. Patient Demographics
- 18.12.8. Deployment Method
- 18.12.9. Treatment Approach
- 18.12.10. End-users
- 18.13. Rest of Asia Pacific Global Neurovascular Devices Market
- 18.13.1. Country Segmental Analysis
- 18.13.2. Product Type
- 18.13.3. Procedure Type
- 18.13.4. Technology
- 18.13.5. Material Type
- 18.13.6. Indication/Disease Type
- 18.13.7. Patient Demographics
- 18.13.8. Deployment Method
- 18.13.9. Treatment Approach
- 18.13.10. End-users
- 19. Middle East Global Neurovascular Devices Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Middle East Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, 2021-2035
- 19.3.1. Product Type
- 19.3.2. Procedure Type
- 19.3.3. Technology
- 19.3.4. Material Type
- 19.3.5. Indication/Disease Type
- 19.3.6. Patient Demographics
- 19.3.7. Deployment Method
- 19.3.8. Treatment Approach
- 19.3.9. End-users
- 19.3.10. Country
- 19.3.10.1. Turkey
- 19.3.10.2. UAE
- 19.3.10.3. Saudi Arabia
- 19.3.10.4. Israel
- 19.3.10.5. Rest of Middle East
- 19.4. Turkey Global Neurovascular Devices Market
- 19.4.1. Country Segmental Analysis
- 19.4.2. Product Type
- 19.4.3. Procedure Type
- 19.4.4. Technology
- 19.4.5. Material Type
- 19.4.6. Indication/Disease Type
- 19.4.7. Patient Demographics
- 19.4.8. Deployment Method
- 19.4.9. Treatment Approach
- 19.4.10. End-users
- 19.5. UAE Global Neurovascular Devices Market
- 19.5.1. Country Segmental Analysis
- 19.5.2. Product Type
- 19.5.3. Procedure Type
- 19.5.4. Technology
- 19.5.5. Material Type
- 19.5.6. Indication/Disease Type
- 19.5.7. Patient Demographics
- 19.5.8. Deployment Method
- 19.5.9. Treatment Approach
- 19.5.10. End-users
- 19.6. Saudi Arabia Global Neurovascular Devices Market
- 19.6.1. Country Segmental Analysis
- 19.6.2. Product Type
- 19.6.3. Procedure Type
- 19.6.4. Technology
- 19.6.5. Material Type
- 19.6.6. Indication/Disease Type
- 19.6.7. Patient Demographics
- 19.6.8. Deployment Method
- 19.6.9. Treatment Approach
- 19.6.10. End-users
- 19.7. Israel Global Neurovascular Devices Market
- 19.7.1. Country Segmental Analysis
- 19.7.2. Product Type
- 19.7.3. Procedure Type
- 19.7.4. Technology
- 19.7.5. Material Type
- 19.7.6. Indication/Disease Type
- 19.7.7. Patient Demographics
- 19.7.8. Deployment Method
- 19.7.9. Treatment Approach
- 19.7.10. End-users
- 19.8. Rest of Middle East Global Neurovascular Devices Market
- 19.8.1. Country Segmental Analysis
- 19.8.2. Product Type
- 19.8.3. Procedure Type
- 19.8.4. Technology
- 19.8.5. Material Type
- 19.8.6. Indication/Disease Type
- 19.8.7. Patient Demographics
- 19.8.8. Deployment Method
- 19.8.9. Treatment Approach
- 19.8.10. End-users
- 20. Africa Global Neurovascular Devices Market Analysis
- 20.1. Key Segment Analysis
- 20.2. Regional Snapshot
- 20.3. Africa Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, 2021-2035
- 20.3.1. Product Type
- 20.3.2. Procedure Type
- 20.3.3. Technology
- 20.3.4. Material Type
- 20.3.5. Indication/Disease Type
- 20.3.6. Patient Demographics
- 20.3.7. Deployment Method
- 20.3.8. Treatment Approach
- 20.3.9. End-users
- 20.3.10. Country
- 20.3.10.1. South Africa
- 20.3.10.2. Egypt
- 20.3.10.3. Nigeria
- 20.3.10.4. Algeria
- 20.3.10.5. Rest of Africa
- 20.4. South Africa Global Neurovascular Devices Market
- 20.4.1. Country Segmental Analysis
- 20.4.2. Product Type
- 20.4.3. Procedure Type
- 20.4.4. Technology
- 20.4.5. Material Type
- 20.4.6. Indication/Disease Type
- 20.4.7. Patient Demographics
- 20.4.8. Deployment Method
- 20.4.9. Treatment Approach
- 20.4.10. End-users
- 20.5. Egypt Global Neurovascular Devices Market
- 20.5.1. Country Segmental Analysis
- 20.5.2. Product Type
- 20.5.3. Procedure Type
- 20.5.4. Technology
- 20.5.5. Material Type
- 20.5.6. Indication/Disease Type
- 20.5.7. Patient Demographics
- 20.5.8. Deployment Method
- 20.5.9. Treatment Approach
- 20.5.10. End-users
- 20.6. Nigeria Global Neurovascular Devices Market
- 20.6.1. Country Segmental Analysis
- 20.6.2. Product Type
- 20.6.3. Procedure Type
- 20.6.4. Technology
- 20.6.5. Material Type
- 20.6.6. Indication/Disease Type
- 20.6.7. Patient Demographics
- 20.6.8. Deployment Method
- 20.6.9. Treatment Approach
- 20.6.10. End-users
- 20.7. Algeria Global Neurovascular Devices Market
- 20.7.1. Country Segmental Analysis
- 20.7.2. Product Type
- 20.7.3. Procedure Type
- 20.7.4. Technology
- 20.7.5. Material Type
- 20.7.6. Indication/Disease Type
- 20.7.7. Patient Demographics
- 20.7.8. Deployment Method
- 20.7.9. Treatment Approach
- 20.7.10. End-users
- 20.8. Rest of Africa Global Neurovascular Devices Market
- 20.8.1. Country Segmental Analysis
- 20.8.2. Product Type
- 20.8.3. Procedure Type
- 20.8.4. Technology
- 20.8.5. Material Type
- 20.8.6. Indication/Disease Type
- 20.8.7. Patient Demographics
- 20.8.8. Deployment Method
- 20.8.9. Treatment Approach
- 20.8.10. End-users
- 21. South America Global Neurovascular Devices Market Analysis
- 21.1. Key Segment Analysis
- 21.2. Regional Snapshot
- 21.3. Central and South Africa Global Neurovascular Devices Market Size (Value - USD Bn and Volume - Million Units), Analysis, and Forecasts, 2021-2035
- 21.3.1. Product Type
- 21.3.2. Procedure Type
- 21.3.3. Technology
- 21.3.4. Material Type
- 21.3.5. Indication/Disease Type
- 21.3.6. Patient Demographics
- 21.3.7. Deployment Method
- 21.3.8. Treatment Approach
- 21.3.9. End-users
- 21.3.10. Country
- 21.3.10.1. Brazil
- 21.3.10.2. Argentina
- 21.3.10.3. Rest of South America
- 21.4. Brazil Global Neurovascular Devices Market
- 21.4.1. Country Segmental Analysis
- 21.4.2. Product Type
- 21.4.3. Procedure Type
- 21.4.4. Technology
- 21.4.5. Material Type
- 21.4.6. Indication/Disease Type
- 21.4.7. Patient Demographics
- 21.4.8. Deployment Method
- 21.4.9. Treatment Approach
- 21.4.10. End-users
- 21.5. Argentina Global Neurovascular Devices Market
- 21.5.1. Country Segmental Analysis
- 21.5.2. Product Type
- 21.5.3. Procedure Type
- 21.5.4. Technology
- 21.5.5. Material Type
- 21.5.6. Indication/Disease Type
- 21.5.7. Patient Demographics
- 21.5.8. Deployment Method
- 21.5.9. Treatment Approach
- 21.5.10. End-users
- 21.6. Rest of South America Global Neurovascular Devices Market
- 21.6.1. Country Segmental Analysis
- 21.6.2. Product Type
- 21.6.3. Procedure Type
- 21.6.4. Technology
- 21.6.5. Material Type
- 21.6.6. Indication/Disease Type
- 21.6.7. Patient Demographics
- 21.6.8. Deployment Method
- 21.6.9. Treatment Approach
- 21.6.10. End-users
- 22. Key Players/ Company Profile
- 22.1. Abbott Laboratories (Abbott Vascular)
- 22.1.1. Company Details/ Overview
- 22.1.2. Company Financials
- 22.1.3. Key Customers and Competitors
- 22.1.4. Business/ Industry Portfolio
- 22.1.5. Product Portfolio/ Specification Details
- 22.1.6. Pricing Data
- 22.1.7. Strategic Overview
- 22.1.8. Recent Developments
- 22.2. Acandis GmbH
- 22.3. Asahi Intecc Co., Ltd.
- 22.4. Balt Extrusion (Balt Group)
- 22.5. Boston Scientific Corporation
- 22.6. Cerus Endovascular
- 22.7. Imperative Care, Inc.
- 22.8. InNeuroCo, Inc.
- 22.9. Integer Holdings Corporation
- 22.10. Johnson & Johnson (Cerenovus)
- 22.11. Medtronic plc
- 22.12. Merit Medical Systems, Inc.
- 22.13. MicroPort Scientific Corporation
- 22.14. MicroVention, Inc. (Terumo Corporation)
- 22.15. Penumbra, Inc.
- 22.16. Perflow Medical Ltd.
- 22.17. Phenox GmbH
- 22.18. Rapid Medical Ltd.
- 22.19. Stryker Corporation
- 22.20. Zylox-Tonbridge Medical Technology Co., Ltd.
- 22.21. Other Key Players
- 22.1. Abbott Laboratories (Abbott Vascular)
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase and Others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players product portfolio
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources includes primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
